• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·300358.SZ
Share

Truking Technology Limited Stocks

CN¥ 8.79Last Updated 26.05.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 783.93M

CN¥ 8.79
Key Takeaways

Risk factor

Meaningful price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very weak growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Truking Technology Limited engages in the research and development of pharmaceutical and medical equipment in China. The company offers solutions for sterile products lyophilization, ampoule injectable products, vial injectable products, vial(powder) products, pre-filling and sealing products, plastic bottle blow-fill-seal, cartridge, non-PVC soft bag, and glass infusion bottle production, as well as fluid processing systems. It also offers isolating systems and lyophilization laboratory. The company exports its products to approximately 40 countries and regions in Asia, Europe, South America, and internationally. Truking Technology Limited was founded in 2000 and is headquartered in Changsha, China.

Company Valuation

Slightly undervalued
5/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of f

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.05.2026 15:58

Morning in New York: geopolitics and macro statistics sway volatility

28.05.2026 15:12

Traders are upping the ante against small-cap companies. What do they fear?

28.05.2026 14:10

Nebius shares soared: its shareholder turned out to be an important AI investor who worked at OpenAI

28.05.2026 13:45

Rallying 35%: report and Amazon partnership revive interest in Snowflake stock

28.05.2026 12:53

Meta has started selling AI subscriptions to chatbot and social networks. The shares jumped by 4%

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026